PlasmaTech Biopharmaceuticals (PTBI): Soros Fund Reveals 5.17 Percent Stake

George Soros’s Fund Management has taken a new 1.16 million share, or 5.17%, stake in PlasmaTech Biopharmaceuticals (PTBI).

In after hours trade on Monday, PlasmaTech shares were up $1.43, or 50.00%, to $4.24.

Soros’s latest 13G filing with the SEC shows that the investing legend’s fund increased its stake in the Dallas, Texas-based company substantially, adding as much as 366% from the 250,000 shares held at the end of the latest quarter ending Dec. 31, 2014.

In the past 52 weeks, shares of the biopharmaceutical company have traded between a low of $2.75 and a high of $26.00. Shares are up 484% yoy ; down 17% year-to-date.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.